Diabetes is a widespread chronic health condition that lasts for life. Many people with insulin-treated diabetes rely on complex calculations and human memory to estimate their insulin doses, which they must do several times a day. As well as being an enormous mental burden, poor management can lead to additional health problems; a large dose can even be fatal.
PEPPER, short for Patient Empowerment through Predictive PERsonalised decision support, tries to tackle this problem by utilising portable technology, together with artificial intelligence (AI) and mathematical modelling, to give people freedom from daily decision-making. The project has created a tool that makes predictions based on real-time data, gathered from unobtrusive, wearable devices, in order to empower individuals to manage their condition more easily. The resulting application has potential benefit to society by improving health outcomes and thereby reducing costs.
Currently there is no decision support system for insulin dosing on the market that adapts itself based on real-time activity data and blood glucose data. The PEPPER project has addressed this by providing personalised decision support on two alternative mobile platforms: one based on a smartphone, and another via the handset of a minimally obtrusive patch pump, which is about the size of a tic-tac box and was manufactured by Cellnovo Ltd (Figure 1). The company went into administration on 26 March 2019 however. Therefore the API delivered here is not a single integrated solution, but rather a collection of individual APIs that comprise the constituent parts of PEPPER.
Users of the system also wear a fitness band and a continuous glucose monitor, which is around the size of a small USB stick. Additional information, such as carbohydrate consumption and alcohol intake, can be added manually on the handset (Figure 2). The PEPPER system is also designed to offer improvement in interactions between individuals and health professionals via a secure, cloud-based server.
The system design process involved users at every stage to ensure that it meets patient needs and raises clinical outcomes as well as improving lifestyle, monitoring and quality of life. Prototypes of the system were demonstrated at various stages to a community of stakeholders including individuals with Type 1 Diabetes, the Vice-President of Diabetes UK, the Director of Research Partnerships from the Juvenile Diabetes Research Foundation (JDRF) and a representative of the Sociedad Española de Endocrinología y Nutrición. Tim Omer, representing the Nightscout patient community, said "as we capture higher quality and quantity of data about our condition, it is refreshing to finally see progress in assisting the patient with analysing this data to provide actionable feedback to reduce the burden of Type 1 Diabetes".
PEPPER draws together computer scientists, clinicians and industry leaders to create and clinically validate this ground-breaking tool. The project, funded by the Horizon 2020 programme, runs from 1 February 2016 until 31 January 2020 and originally included six partners from three countries: Oxford Brookes University, Imperial College London, University de Girona, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Romsoft SRL and Cellnovo Ltd. Following the liquidation of the latter company, the consortium was reduced to the remaining five members however. The approach used and resulting system architecture provide a generic framework for providing adaptive decision support anytime, anywhere, which could be applied to other health conditions that are monitored by wearable technology.
Each of the individual APIs is produced by a different partner within the PEPPER consortium. As such, the licensing and contact information of each component corresponds to the organisation responsible.
The presentation of each API comprises four pages:
There are four separate code bases within the PEPPER API. All except for the web interface were written in Java or Javascript. Figure 3 is a representation of how the components of the original PEPPER system interoperated and shows how the individual APIs fit within it. The central component of the PEPPER system is the insulin recommender system, which calculates the bolus dose from the various sources of physiological, dietary, physical activity and environmental data. The resulting dose is constrained by the safety system, which keeps the recommendation within a safe range, as well as providing additional safety-critical features. Data is synchronised with a cloud-based server, which provides the web interface to clinicians. The mobile handset contains the logic that draws together each of these component parts. Figure 3 is split into two sections:
This project has received funding from the EU Horizon 2020 programme, grant agreement No. 689810.